Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Futao Meng"'
Autor:
Fang Xie, Mei Huang, Xiansheng Lin, Chenhai Liu, Zhen Liu, Futao Meng, Chao Wang, Qiang Huang
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/44d6558958f24c378a96382cae038961
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chronic pancreatitis (CP) is a precancerous condition associated with pancreatic ductal adenocarcinoma (PDAC), but its evolutionary mechanism is unclear. Pancreatic stellate cells (PSCs) are closely related to the occurrence and development of CP and
Externí odkaz:
https://doaj.org/article/6d0cb56dfebb47c898f7425268f0cc7b
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
Gemcitabine resistance is currently the main problem of chemotherapy for advanced pancreatic cancer patients. The resistance is thought to be caused by altered drug metabolism or reduced apoptosis of cancer cells. However, the underlying mechanism of
Externí odkaz:
https://doaj.org/article/40a36a6e94a34e2d865bbc9c91c089ed
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
Chronic pancreatitis (CP) is a precancerous condition associated with pancreatic ductal adenocarcinoma (PDAC), but its evolutionary mechanism is unclear. Pancreatic stellate cells (PSCs) are closely related to the occurrence and development of CP and
Autor:
Xiansheng Lin, Qiang Huang, Chenhai Liu, Mei Huang, Futao Meng, Chao Wang, Fang Xie, Zhen Liu
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
Scientific Reports
Scientific Reports
As one of the most fatal malignancies, pancreatic ductal adenocarcinoma (PDAC) has significant resistance to the currently available treatment approaches. Gemcitabine, the standard chemotherapeutic agent for locally advanced and metastatic PDAC, has